14-75047634-A-AT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_001040108.2(MLH3):c.2021dupA(p.Asn674fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,412 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000062 ( 0 hom. )
Consequence
MLH3
NM_001040108.2 frameshift
NM_001040108.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.505
Genes affected
MLH3 (HGNC:7128): (mutL homolog 3) This gene is a member of the MutL-homolog (MLH) family of DNA mismatch repair (MMR) genes. MLH genes are implicated in maintaining genomic integrity during DNA replication and after meiotic recombination. The protein encoded by this gene functions as a heterodimer with other family members. Somatic mutations in this gene frequently occur in tumors exhibiting microsatellite instability, and germline mutations have been linked to hereditary nonpolyposis colorectal cancer type 7 (HNPCC7). Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BS2
High AC in GnomAdExome4 at 9 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLH3 | ENST00000355774.7 | c.2021dupA | p.Asn674fs | frameshift_variant | 2/13 | 5 | NM_001040108.2 | ENSP00000348020.2 | ||
MLH3 | ENST00000380968.6 | c.2021dupA | p.Asn674fs | frameshift_variant | 2/12 | 1 | ENSP00000370355.3 | |||
MLH3 | ENST00000556257.5 | c.2021dupA | p.Asn674fs | frameshift_variant | 2/7 | 5 | ENSP00000451540.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151944Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
151944
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250086Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135188
GnomAD3 exomes
AF:
AC:
1
AN:
250086
Hom.:
AF XY:
AC XY:
0
AN XY:
135188
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461468Hom.: 0 Cov.: 35 AF XY: 0.00000550 AC XY: 4AN XY: 727000
GnomAD4 exome
AF:
AC:
9
AN:
1461468
Hom.:
Cov.:
35
AF XY:
AC XY:
4
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151944Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74210
GnomAD4 genome
AF:
AC:
4
AN:
151944
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2023 | The c.2021dupA variant, located in coding exon 1 of the MLH3 gene, results from a duplication of A at nucleotide position 2021, causing a translational frameshift with a predicted alternate stop codon (p.N674Kfs*13). This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. - |
Colorectal cancer, hereditary nonpolyposis, type 7 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 26, 2019 | This variant is present in population databases (rs767782578, ExAC 0.01%) but has not been reported in the literature in individuals with a MLH3-related disease. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MLH3 cause disease. Therefore, this variant has been classified as a Variant of Uncertain Significance. This sequence change inserts 1 nucleotide in exon 2 of the MLH3 mRNA (c.2021dupA), causing a frameshift at codon 674. This creates a premature translational stop signal (p.Asn674Lysfs*13) and is expected to result in an absent or disrupted protein product. - |
Endometrial carcinoma Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | May 16, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at